Search Grant Opportunities

Anesthetics for Battlefield Care (ABC)

ID: HR001123S0038 • Type: Posted

Description

Anesthetics are remarkable drugs that have long-enabled surgical interventions, but their inherent lack of safety necessitates careful monitoring nearly exclusively within an operating room environment. The Anesthetics for Battlefield Care (ABC) program will test the hypothesis that therapeutic effects of anesthetics can be uncoupled/separated from deleterious effects. ABC endeavors to produce drugs for use in traumatic injury capable of safe, unmonitored anesthesia to enable earlier life-saving interventions, reduce the trauma associated with battlefield-injury, and thereby improve combat casualty outcomes.
Background
The Anesthetics for Battlefield Care (ABC) program is a Broad Agency Announcement (BAA) issued by the Defense Advanced Research Projects Agency (DARPA), Biological Technologies Office (BTO). The program aims to produce drugs for use in traumatic injury capable of safe, unmonitored anesthesia to enable earlier life-saving interventions, reduce the trauma associated with battlefield-injury, and improve combat casualty outcomes.

Grant Details
The ABC program is divided into two sequential phases totaling 60 months. Phase 1 is 36 months and Phase 2 is 24 months. The program has two Technical Areas (TAs): TA1 is Discovery, focusing on uncovering novel targets and mechanisms involved in anesthesia and validating those targets. TA2 is Medicinal Chemistry, involving the design of chemical compounds that work through the targets identified in TA1 to achieve a safer anesthetic state. The program has specific milestones and metrics for each phase, including demonstrating target contribution to anesthesia, producing battlefield-ready intervention for inducing anesthesia, and demonstrating safety and efficacy of interventions in a healthy mammalian model.

Eligibility Requirements
Eligible applicants include proposer teams with the expertise needed to achieve the goals of both TA1 and TA2. University or non-profit research institution performance under this solicitation will include effort categorized as fundamental research. Performers are required to comply with due diligence to identify Foreign Components or participation by Senior/Key Personnel in Foreign Government Talent Recruitment Programs.

Period of Performance
The program spans over 60 months. A Go/No-Go demonstration will occur at 36 months, and successful fulfillment of the criteria will be required for progression into phase 2. The end of the program evaluation will occur at month 60.

Grant Value
Multiple awards are anticipated under this BAA. The amount of resources made available will depend on the quality of the proposals received and the availability of funds.

Overview

Category of Funding
Science and Technology and other Research and Development
Funding Instruments
Cooperative Agreement
Other
Procurement Contract
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 6/9/23 Defense Advanced Research Projects Agency posted grant opportunity HR001123S0038 for Anesthetics for Battlefield Care (ABC). The grant will be issued under grant program 12.910 Research and Technology Development.

Timing

Posted Date
June 9, 2023, 12:00 a.m. EDT
Closing Date
Aug. 21, 2023, 12:00 a.m. EDT Past Due
Closing Date Explanation
See Full Announcement for details.
Last Updated
June 9, 2023, 2:41 p.m. EDT
Version
1
Archive Date
Sept. 20, 2023

Eligibility

Eligible Applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Info
All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information.

Contacts

Contact
DARPA - Biological Technologies Office
Contact Email
Email Description
None
Contact Phone
(571) 218-4963
Additional Information
SAM.gov Contract Opportunities

Documents

Posted documents for HR001123S0038

Grant Awards

Grants awarded through HR001123S0038

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to HR001123S0038